|
|
 |
ANHYDROUS CITRIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
WHITE WAX Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VYONDYS 53 Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIO METHACRYLATE COPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
VYXEOS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|